Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy

  1. Zabaleta, A.
  2. Puig, N.
  3. Cedena, M.-T.
  4. Oliver-Caldes, A.
  5. Perez, J.J.
  6. Moreno, C.
  7. Tamariz-Amador, L.-E.
  8. Rodriguez-Otero, P.
  9. Prosper, F.
  10. Gonzalez-Calle, V.
  11. López-Corral, L.
  12. Rey-Búa, B.
  13. Puertas, B.
  14. Mirás, F.
  15. Sánchez-Pina, J.M.
  16. López-Muñoz, N.
  17. Juan, M.
  18. González-Navarro, E.A.
  19. Urbano, Á.
  20. de Larrea, C.F.
  21. Blade, J.
  22. Lahuerta, J.-J.
  23. Martinez-Lopez, J.
  24. Mateos, M.-V.
  25. San Miguel, J.F.
  26. Paiva, B.
  27. Show all authors +
Journal:
American Journal of Hematology

ISSN: 1096-8652 0361-8609

Year of publication: 2025

Volume: 100

Issue: 1

Pages: 93-102

Type: Article

DOI: 10.1002/AJH.27526 GOOGLE SCHOLAR lock_openOpen access editor